First Foundation Advisors Buys New Stake in Express Scripts Holding Co (ESRX)

First Foundation Advisors bought a new stake in shares of Express Scripts Holding Co (NASDAQ:ESRX) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 2,167 shares of the company’s stock, valued at approximately $206,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Sowell Financial Services LLC bought a new stake in shares of Express Scripts in the third quarter worth about $719,000. Mirae Asset Global Investments Co. Ltd. increased its holdings in shares of Express Scripts by 64.4% in the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 85,496 shares of the company’s stock worth $8,118,000 after purchasing an additional 33,483 shares during the last quarter. Hsbc Holdings PLC increased its holdings in shares of Express Scripts by 36.4% in the third quarter. Hsbc Holdings PLC now owns 958,566 shares of the company’s stock worth $91,061,000 after purchasing an additional 255,961 shares during the last quarter. Stevens Capital Management LP bought a new stake in shares of Express Scripts in the third quarter worth about $8,903,000. Finally, Ativo Capital Management LLC bought a new stake in shares of Express Scripts in the third quarter worth about $952,000. Institutional investors own 85.02% of the company’s stock.

Shares of NASDAQ ESRX opened at $100.64 on Tuesday. The company has a current ratio of 0.77, a quick ratio of 0.65 and a debt-to-equity ratio of 0.63. Express Scripts Holding Co has a 1-year low of $65.31 and a 1-year high of $101.73. The company has a market cap of $57.21 billion, a price-to-earnings ratio of 14.17, a P/E/G ratio of 1.28 and a beta of 0.88.

Express Scripts (NASDAQ:ESRX) last issued its quarterly earnings data on Wednesday, October 31st. The company reported $2.43 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.42 by $0.01. Express Scripts had a return on equity of 25.43% and a net margin of 4.83%. The company had revenue of $25.56 billion for the quarter, compared to analysts’ expectations of $25.11 billion. During the same period in the previous year, the firm posted $2.51 earnings per share. The firm’s revenue for the quarter was up 3.6% on a year-over-year basis. As a group, analysts predict that Express Scripts Holding Co will post 9.08 EPS for the current fiscal year.

In other Express Scripts news, Director Mahon Thomas P. Mac sold 5,234 shares of the business’s stock in a transaction that occurred on Wednesday, November 7th. The stock was sold at an average price of $99.50, for a total transaction of $520,783.00. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Insiders own 0.79% of the company’s stock.

Several brokerages have recently issued reports on ESRX. Zacks Investment Research cut Express Scripts from a “buy” rating to a “hold” rating in a report on Tuesday, November 27th. Mizuho set a $101.00 target price on Express Scripts and gave the stock a “hold” rating in a report on Monday, November 5th. William Blair cut Express Scripts from an “outperform” rating to a “market perform” rating in a report on Wednesday, October 31st. Cowen reaffirmed a “buy” rating and issued a $88.00 target price on shares of Express Scripts in a report on Friday, November 2nd. Finally, Barclays lifted their target price on Express Scripts from $83.00 to $90.00 and gave the stock an “equal weight” rating in a report on Thursday, November 1st. One equities research analyst has rated the stock with a sell rating, fourteen have given a hold rating, five have given a buy rating and one has given a strong buy rating to the company’s stock. Express Scripts currently has an average rating of “Hold” and a consensus price target of $90.60.

WARNING: “First Foundation Advisors Buys New Stake in Express Scripts Holding Co (ESRX)” was published by Community Financial News and is the sole property of of Community Financial News. If you are reading this article on another publication, it was stolen and reposted in violation of United States & international copyright laws. The correct version of this article can be viewed at https://www.com-unik.info/2018/12/04/first-foundation-advisors-buys-new-stake-in-express-scripts-holding-co-esrx.html.

Express Scripts Profile

Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.

Recommended Story: What is Compound Interest?

Institutional Ownership by Quarter for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit